The Outlook for BRAF Inhibitors in Melanoma
Antoni Ribas, MD, PhD, professor of medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, discusses the outlook for BRAF inhibitors in melanoma.
Antoni Ribas, MD, PhD, professor of medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, discusses the outlook for BRAF inhibitors in melanoma.
Read more about BRAF inhibitors for the treatment of melanoma andadvances in metastatic disease
Articles in this issue
Two BRAF Fusions Discovered in Some Pan-Negative Melanomas
Understanding the Biologic Pathways in Basal Cell Carcinoma
Advances in Metastatic Melanoma
Targeted and Immunotherapy in Metastatic Melanoma: An Interview With Jeffrey S Weber, MD, PhD
Targeted Therapies in Basal Cell Carcinoma
The Outlook for BRAF Inhibitors in Melanoma
Combinations and Immunotherapies Detailed at Society for Melanoma Research 10th International Meeting
The Treatment of Melanoma With Emerging Targeted Therapies
The Challenges of Treating Metastatic Melanoma With BRAF Inhibitor Monotherapy
Recent Videos
Related Content
